Friday, January 30, 2015

ALFREZZA - Inhalable rapid Insulin


US FDA has approved an inhalable rapid insulin after several years of field trials and review. The drug is now reported to be available at several Pharmacies across USA.

It is priced in the range of 200-270USD when compared to the 300-400USD price of insulin injection.

The procedure to use use AFREZZA is as follows,

Further details : http://www.mannkindcorp.com/collateral/documents/english-us/afrezza_prescribinginformation.pdf

http://www.forbes.com/sites/kenkam/2015/01/27/afrezza-breathes-life-into-mannkind/


No comments:

Post a Comment